Lexicon Pharmaceuticals (LXRX) Inventory (2017 - 2026)
Lexicon Pharmaceuticals (LXRX) reported Inventory of $276000.0 for Q1 2026, up 37.31% year-over-year from $201000.0 in Q1 2025, and down 1.78% quarter-over-quarter from $281000.0 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Inventory (2017 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 8 years of Inventory data on file, last reported at $276000.0 in Q1 2026.
- Inventory for Q1 2026 came in at $276000.0, up 37.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $276000.0 (up 37.31% YoY), and the FY2025 annual result was $281000.0, up 21.65% from the prior year.
- Inventory retreated to $276000.0 in Q1 2026 per LXRX's latest filing, from $281000.0 in the prior quarter.
- Over five years, Inventory peaked at $636000.0 in Q3 2024 and troughed at $158000.0 in Q3 2025.
- A 4-year average of $328250.0 and a median of $278500.0 in 2025 frame the typical range for Inventory.
- The sharpest annual moves came in 2024 and 2025: Inventory soared 240.12% in 2024, then plunged 75.16% in 2025.
- A 4-year view of Inventory shows it stood at $381000.0 in 2023, then slumped by 39.37% to $231000.0 in 2024, then climbed by 21.65% to $281000.0 in 2025, then slipped by 1.78% to $276000.0 in 2026.
- Business Quant data shows LXRX's Inventory at $276000.0 in Q1 2026, $281000.0 in Q4 2025, and $158000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 32.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.77 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 804.48 Mn | 633.82 Mn | 20.99 Mn | 276,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 276,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Sep 30, 2025 | 158,000.00 |
| Jun 30, 2025 | 168,000.00 |
| Mar 31, 2025 | 201,000.00 |
| Dec 31, 2024 | 231,000.00 |
| Sep 30, 2024 | 636,000.00 |
| Jun 30, 2024 | 585,000.00 |
| Mar 31, 2024 | 514,000.00 |
| Dec 31, 2023 | 381,000.00 |
| Sep 30, 2023 | 336,000.00 |
| Jun 30, 2023 | 172,000.00 |
| Jun 30, 2020 | 3.99 Mn |
| Mar 31, 2020 | 4.15 Mn |
| Dec 31, 2019 | 4.24 Mn |
| Sep 30, 2019 | 4.48 Mn |
| Jun 30, 2019 | 4.28 Mn |
| Mar 31, 2019 | 4.61 Mn |
| Dec 31, 2018 | 4.68 Mn |
| Sep 30, 2018 | 4.76 Mn |